← Back to Search

Faith in Action! Church-based Navigation for Breast Cancer Screening

N/A
Recruiting
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Korean woman who is 45 years or older
Does not currently have a breast cancer diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial is testing a training curriculum to help laypeople in faith-based settings provide breast cancer screening navigation to Korean American women, to see if it increases adherence to breast cancer screening guidelines.

Who is the study for?
This trial is for Korean women aged 45 or older who are members of participating Korean churches in Los Angeles and haven't had a mammogram in the last two years. They should not currently have breast cancer but must be willing to participate in the study.Check my eligibility
What is being tested?
The 'Faith in Action!' program trains lay health navigators within churches to encourage Korean American women to follow breast cancer screening guidelines. The effectiveness of this culturally adapted curriculum will be compared with a control group through interviews and randomized trials.See study design
What are the potential side effects?
Since this intervention involves education and support rather than medical treatment, there are no direct side effects like those associated with medications or procedures. However, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a Korean woman aged 45 or older.
Select...
I do not have a current diagnosis of breast cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Screening adherence
Secondary outcome measures
Breast Cancer Screening Beliefs (Knowledge, Perception, and perceived risk)
Change in Knowledge of Breast Cancer Screening
Participant knowledge, attitudes, and beliefs towards screening (Qualitative)
Other outcome measures
Change in NIH PROMIS Global Health

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Faith in Action!Experimental Treatment1 Intervention
A train-the-trainer approach will be used to educate lay health navigators to present the culturally adapted "Faith in Action!" curriculum and to provide breast cancer screening navigation to Korean American women within faith-based settings
Group II: ControlActive Control1 Intervention
A presentation of lifestyle recommendations (e.g., physical activity, nutrition) will be provided to control groups.

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
499 Previous Clinical Trials
164,537 Total Patients Enrolled
17 Trials studying Breast Cancer
2,124 Patients Enrolled for Breast Cancer
California Breast Cancer Research ProgramOTHER
15 Previous Clinical Trials
103,393 Total Patients Enrolled
11 Trials studying Breast Cancer
102,945 Patients Enrolled for Breast Cancer

Media Library

Faith in Action! Church-based Navigation Model Clinical Trial Eligibility Overview. Trial Name: NCT05298605 — N/A
Breast Cancer Research Study Groups: Faith in Action!, Control
Breast Cancer Clinical Trial 2023: Faith in Action! Church-based Navigation Model Highlights & Side Effects. Trial Name: NCT05298605 — N/A
Faith in Action! Church-based Navigation Model 2023 Treatment Timeline for Medical Study. Trial Name: NCT05298605 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently receiving treatment through this experiment?

"Affirmative. Clinicaltrials.gov hosts information that confirms this study, initiated on July 16th 2022, is actively seeking participants. As such, 320 individuals across 2 sites must be recruited for the trial to continue."

Answered by AI

Are there any available openings left in this experiment for participants?

"Affirmative. The information listed on clinicaltrials.gov confirms that this research trial, which was initially posted on July 16th 2022, is now actively enrolling individuals. A total of 320 participants are needed from 2 distinct sites."

Answered by AI

Does this trial require participants to be of legal age?

"This clinical trial seeks to enrol patients who are between 45 years of age and 80 years old."

Answered by AI

What criteria must individuals meet to take part in this medical experiment?

"Those wishing to take part in this clinical trial must be between 45 and 80 years of age, as well as being diagnosed with a neoplasm. Currently 320 applicants are needed for the study."

Answered by AI
~28 spots leftby Jul 2024